| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.6M | +11.9% |
| Cost of Revenue | $42.6M | -11.8% |
| R&D Expense | $241.2M | +54.9% |
| SG&A Expense | $110.8M | +35.8% |
| Operating Income | -$350.1M | -42.5% |
| Interest Expense | $97K | +76.4% |
| Pre-tax Income | -$332.1M | -38.7% |
| Income Tax | -$4.1M | — |
| Net Income | -$328.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.6M | -28.8% |
| Current Assets | $438.1M | -23.1% |
| Total Assets | $653.7M | -6.8% |
| Current Liabilities | $93.2M | -7.1% |
| Total Liabilities | $190.3M | -11.7% |
| Stockholders' Equity | $463.4M | -4.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$287.8M | -244.5% |
| Capital Expenditures | $12.0M | -67.7% |
| Investing Cash Flow | -$10.2M | -105.3% |
| Financing Cash Flow | $140.1M | -9.2% |
| Free Cash Flow | -$299.7M | -148.6% |
| -37.0% |
| EPS (Basic) | -$1.58 | -16.2% |
| EPS (Diluted) | -$1.58 | -16.2% |